Santa Cruz Biotechnology

BML-275-2 | Santa Cruz Biotechnology

(0) Write Review

ACTR-I Inhibitor, AMPK Inhibitor, BMPR-IA Inhibitor, BMPR-IB Inhibitor, Fatty Acid Synthase Inhibitor, BML-275 is a Cell-permeable pyrrazolopyrimidine derivative and potent, selective, ATP-competitive inhibitor of AMPK in fatty acid biosynthesis.

Learn More

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars